Researchers are the first to fully characterize a special type of stem cell, endothelial progenitor cells (EPCs) that exist in circulating blood, to see if they can behave as endothelial cells in the body when cultured on a bioengineered surface. The results show promise for a new generation of tissue-engineered vascular grafts which could improve the success rate of surgery for peripheral arterial disease.